2020 Annual Global Meeting: Virtual-Plenary II: Oral Abstract Presentation

Video Transcription

Video Summary

Thank you all for joining us for this session on endometrial cancer. We heard presentations on various topics related to endometrial cancer, including the role of molecular subtyping, the use of sentinel lymph node biopsy, and the impact of frailty on surgical outcomes. Dr. Thompson discussed the use of molecular classification to stratify endometrial cancer into prognostically relevant risk groups. She emphasized the importance of identifying the molecular subtypes in order to guide treatment decisions and improve outcomes. Dr. Cusimano presented findings from a prospective multicenter study which evaluated the diagnostic accuracy of sentinel lymph node biopsy in patients with intermediate and high-grade endometrial cancer. The study found that sentinel lymph node biopsy had excellent performance characteristics in this patient population. Dr. Arletti discussed the role of intrauterine manipulator in laparoscopic or robotic hysterectomy for low-risk endometrial cancer. The study found that the use of a manipulator did not affect pathological outcomes or oncological outcomes in these patients. Finally, Dr. Nakla presented findings on the impact of frailty on surgical outcomes in patients undergoing procedures for endometrial cancer. The study found that frailty was independently associated with worse outcomes and increased resource use. Overall, these presentations highlight the importance of molecular classification, sentinel lymph node biopsy, and careful assessment of patient factors in the management of endometrial cancer. Thank you for attending this session.

Keywords

endometrial cancer

molecular subtyping

sentinel lymph node biopsy

frailty

surgical outcomes

molecular classification

prognostically relevant risk groups

diagnostic accuracy

intrauterine manipulator

laparoscopic hysterectomy